The RPE of Ayala Pharmaceuticals Inc. is $11.111k
Revenue per employee (RPE) is revenue divided by the number of employees of an organization.
= net income / number of employees
advaxis (nasdaq: adxs) is a late -stage biotechnology company developing multiple cancer immunotherapies based on its proprietary platform that redirects the immune system to kill cancer. the advaxis technology, using bioengineered live attenuated bacteria, listeria monocytogenes (lm), actively suppresses key components in the tumor microenvironment that contribute to the tumors growth and protection from immunologic attack.